Acura Pharmaceuticals, Inc. (ACUR)
OTCMKTS · Delayed Price · Currency is USD
0.0010
+0.0008 (400.00%)
Jan 21, 2025, 3:00 PM EST

Acura Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 2016 - 2012
Period Ending
Dec '21 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 2016 - 2012
Net Income
-0.88-0.88-1.21-3.77-3.84-5.68
Upgrade
Depreciation & Amortization
0.090.090.130.270.280.29
Upgrade
Other Amortization
---0.070.090.1
Upgrade
Loss (Gain) From Sale of Assets
---0--0
Upgrade
Asset Writedown & Restructuring Costs
0.050.050.67---
Upgrade
Stock-Based Compensation
0.060.060.040.110.220.46
Upgrade
Other Operating Activities
-0.54-0.54-0.222.59-0.470.05
Upgrade
Change in Accounts Receivable
0.470.47-0.47-0.02-0.070.08
Upgrade
Change in Inventory
-----0.1
Upgrade
Change in Accounts Payable
0.160.16-0.21-0.370.6-0.07
Upgrade
Change in Income Taxes
--0.070.07--0.14
Upgrade
Change in Other Net Operating Assets
-0.15-0.150.490.45-0.720.29
Upgrade
Operating Cash Flow
-0.74-0.74-0.72-0.62-3.91-4.51
Upgrade
Other Investing Activities
-----0.31
Upgrade
Investing Cash Flow
-----0.31
Upgrade
Long-Term Debt Issued
0.420.420.271.384.35-
Upgrade
Long-Term Debt Repaid
-0.02-0.02---2.57-2.76
Upgrade
Net Debt Issued (Repaid)
0.40.40.271.381.78-2.76
Upgrade
Issuance of Common Stock
0000.0104
Upgrade
Repurchase of Common Stock
-0.01-0.01-0---
Upgrade
Financing Cash Flow
0.390.390.271.391.781.24
Upgrade
Net Cash Flow
-0.35-0.35-0.450.77-2.13-2.96
Upgrade
Free Cash Flow
-0.74-0.74-0.72-0.62-3.91-4.51
Upgrade
Free Cash Flow Margin
-47.47%-47.47%-20.14%-23.26%-953.17%-152.06%
Upgrade
Free Cash Flow Per Share
-0.01-0.01-0.02-0.02-0.18-0.28
Upgrade
Cash Interest Paid
----0.760.36
Upgrade
Levered Free Cash Flow
-1.1-1.1-0.33-0.57-2.620.96
Upgrade
Unlevered Free Cash Flow
-0.98-0.98-0.04-0.35-2.461.24
Upgrade
Change in Net Working Capital
0.420.420.170.310.53-3.71
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.